XLO 8-K 2026-01-08

Xilio Therapeutics, Inc. (XLO) 8-K dated 2026-01-08 — accession 0001193125-26-007063. This URL is the filing, not the XLO hub.

Xilio Therapeutics, Inc. (XLO) is a biotechnology company listed on NASDAQ.

Xilio Therapeutics, Inc. filed a 8-K on 2026-01-08. Accession 0001193125-26-007063.

Cached items: 2.02, 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported XLO revenue for 2026-06-30 was $31.3M. Net income was -$15.9M. XLO currently screens at market cap $55.3M.

Not investment advice. The XLO SEC hub lists recent forms. The stock page is the research view.